Neofect Co., Ltd. (KOSDAQ:290660)
South Korea · Delayed Price · Currency is KRW 696.00
+17.00 (2.50%)
At close: Jan 20, 2026
Neofect Market Cap
Neofect has a market cap or net worth of 52.19 billion as of January 23, 2026. Its market cap has increased by 26.98% in one year.
Market Cap
52.19B
Enterprise Value
46.14B
Revenue
20.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
696.00
Market Cap Chart
Since November 28, 2018, Neofect's market cap has decreased from 90.23B to 52.19B, a decrease of -42.16%. That is a compound annual growth rate of -7.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 52.19B | 23.81% |
| Dec 30, 2025 | 42.15B | 3.48% |
| Dec 30, 2024 | 40.74B | -6.42% |
| Dec 28, 2023 | 43.53B | 62.18% |
| Dec 29, 2022 | 26.84B | -54.72% |
| Dec 30, 2021 | 59.27B | -9.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuantaMatrix | 91.41B |
| Remed | 86.39B |
| Hironic | 74.74B |
| JPI Healthcare | 73.01B |
| DRGEM | 59.38B |
| Genoray | 51.20B |
| UXN Co., Ltd. | 40.50B |
| CU Medical Systems | 35.35B |